BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 30380405)

  • 1. Insulin Secretion Depends on Intra-islet Glucagon Signaling.
    Svendsen B; Larsen O; Gabe MBN; Christiansen CB; Rosenkilde MM; Drucker DJ; Holst JJ
    Cell Rep; 2018 Oct; 25(5):1127-1134.e2. PubMed ID: 30380405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
    Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
    J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets.
    Svendsen B; Holst JJ
    Diabetologia; 2021 Jan; 64(1):142-151. PubMed ID: 33043402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
    Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
    Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R
    Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.
    Gu W; Winters KA; Motani AS; Komorowski R; Zhang Y; Liu Q; Wu X; Rulifson IC; Sivits G; Graham M; Yan H; Wang P; Moore S; Meng T; Lindberg RA; Véniant MM
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E624-32. PubMed ID: 20647556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism.
    Nakashima K; Kaneto H; Shimoda M; Kimura T; Kaku K
    Sci Rep; 2018 Feb; 8(1):3725. PubMed ID: 29487355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in pancreatic islet cell function in response to small bowel resection.
    Courtney CM; Shyr ZA; Yan Z; Onufer EJ; Steinberger AE; Tecos ME; Barron LK; Guo J; Remedi MS; Warner BW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G36-G42. PubMed ID: 32463335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 preserves β cell function via improvement on islet insulin signaling in high fat diet feeding mice.
    Yang H; Wang S; Ye Y; Xie M; Li Y; Jin H; Li J; Gao L
    Neuropeptides; 2021 Feb; 85():102110. PubMed ID: 33307381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-specific resetting of mouse islet cellular clocks by glucagon, glucagon-like peptide 1 and somatostatin.
    Petrenko V; Dibner C
    Acta Physiol (Oxf); 2018 Apr; 222(4):e13021. PubMed ID: 29271578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y; Ernst SA; Heidenreich K; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
    Fehmann HC; Habener JF
    FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
    Flamez D; Gilon P; Moens K; Van Breusegem A; Delmeire D; Scrocchi LA; Henquin JC; Drucker DJ; Schuit F
    Diabetes; 1999 Oct; 48(10):1979-86. PubMed ID: 10512362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
    Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
    J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice.
    Ling Z; Wu D; Zambre Y; Flamez D; Drucker DJ; Pipeleers DG; Schuit FC
    Virchows Arch; 2001 Apr; 438(4):382-7. PubMed ID: 11355173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats.
    Song X; Sun X; Hao H; Han Q; Han W; Mu Y
    Stem Cells Dev; 2021 May; 30(9):502-514. PubMed ID: 33677993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome.
    Kondo M; Tanabe K; Amo-Shiinoki K; Hatanaka M; Morii T; Takahashi H; Seino S; Yamada Y; Tanizawa Y
    Diabetologia; 2018 Oct; 61(10):2189-2201. PubMed ID: 30054673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.